Top Story

Technology snags may limit adoption of current hybrid closed-loop insulin delivery system

Technology snags may limit adoption of current hybrid closed-loop insulin delivery system
March 23, 2019
Meeting News

Experts debate CAR T-cell therapy vs. transplant for relapsed diffuse large B-cell lymphoma

March 23, 2019
NEW YORK — Chimeric antigen receptor T-cell therapy confers better outcomes than autologous stem cell transplant to some patients with relapsed diffuse large…
Meeting NewsVideo

VIDEO: Retina World Congress a comprehensive educational meeting

March 23, 2019
FORT LAUDERDALE, Fla. — At the Retina World Congress, Baruch D. Kuppermann, MD, director of the Gavin Herbert Eye Institute at the University of California…

Q&A: New Jersey chooses a state microbe

March 23, 2019
The New Jersey state legislature voted unanimously to approve a bill that would name Streptomyces griseus as the official state microbe, and the legislation has been…
Meeting News

At 1 year, aflibercept injections did not impact CNV conversion rates

March 23, 2019
FORT LAUDERDALE, Fla. — Patients with intermediate age-related macular degeneration treated with intravitreal aflibercept injections did not experience improved…
More Headlines »
CME

Curbside Consults in Bipolar Disorder: Selecting and Implementing the Best Medication Regimen for your Patients

This activity is supported by educational grants from Otsuka America Pharmaceutical, Inc. and Lundbeck; and Sunovion Pharmaceuticals Inc.

Bipolar disorder comprises a spectrum of diseases, characterized by recurrent periods of mania, hypomania, or episodes…
More »
Case Report

Choroidal Hemangioma in a Black Patient With Sturge-Weber Syndrome: Challenges in Diagnosis

Ophthalmic Surgery, Lasers and Imaging Retina, March 2019, Volume 50 Issue 3
A black teenager presented with long-standing vision loss in his right eye. Clinical exam revealed increased…
More »
Resource Centers
The Endocrine Society Annual Meeting

The Endocrine Society Annual Meeting

Video
Meeting News

VIDEO: New brand of loteprednol has increased penetration

March 22, 2019
More »